Antibodies that bind human 17-A1/EpCAM tumor antigen

Details Antibodies that bind human 17-A1/EpCAM tumor antigen Antibodies that bind human 17-A1/EpCAM tumor antigen

2007-09-24

2009-12-15

Blanchard, David J. (Department: 1643)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Blood proteins or globulins, e.g., proteoglycans, platelet...

C530S388150, C530S388850, C530S391300, C530S391700, C424S133100, C424S142100, C424S156100, C424S174100, C424S181100, C424S183100, C435S069600, C536S023530

Reexamination Certificate

active

07632925

ABSTRACT:
The present invention provides an anti-human antibody or fragment thereof that is low or not immunogenic in humans. In particular, the antibodies or fragments are directed to human tumor antigens, preferably to the human tumor antigen 17-1A, also known as EpCAM, EGP or GA 733-2. Also provided are pharmaceutical compositions comprising the aforementioned antibodies or fragments thereto.

REFERENCES:
patent: 5565332 (1996-10-01), Hoogenboom et al.
patent: 5885793 (1999-03-01), Griffiths et al.
patent: 6150584 (2000-11-01), Kucherlapati et al.
patent: WO 93/06213 (1993-04-01), None
patent: WO 93/11236 (1993-06-01), None
patent: WO 97/00271 (1997-01-01), None
Amin and Carter, “Immunogenicity issues with therapeutic protein,”Curr Drug Disc, Nov. 20- 24, 2004.
Dermer, “Another anniversary for the war on cancer,”Bio/Technology, 12:320, 1994.
Duenas et al., “In vitro immunization of naïve human B cells yeilds high affinity immunoglublin G antibodies as illustrated by phage display,”Immunology, 89:1-7, 1996.
Figini et al., “In Vitro Assembly of Repertoires of Antibody Chains on the Surface of Phage Renaturation,”J. Mol. Biol., 269:68-78, 1994.
Freshney, Culture of animal cells: a manual of basic technique, Alan R. Liss, Inc., New York p. 4, 1983.
Gottlinger et al., “The epithelial cell surface antigen 17-1A, a target for antibody-medicated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies,”Intl. Journ. Cancer, 38:47-53, 1986.
Gura, “Systems for identifying new drugs are often faulty,”Science, 278:1041-1042, 1997.
Herlyn and Koprowski, “IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells,”Proc Natl Acad Sci USA, 79:4761-4765, 1982.
Herlyn et al., “Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies,”Proc Natl Acad Sci USA,76(3):1438-1442, 1979.
Hoess et al., “Generation of human antibodies that selectively recognize diseased cells overexpressing surface bound antigens,”Proc. Americ. Ass. Canc. Re., 38:30, 1997.
Jain, “Barriers to drug delivery in solid tumors,”Sci Am, 271(1):58-65, 1994.
Krebber et al., “Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoire employing a reengineered phage display system,”Journ. Immunological Methods, 201:35-35, 1997.
Litvinov et al., “Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule,”J Cell Biol, 125(2):437-446, 1994.
LoBuglio et al., “Mouse/human chimeric monoclonal antibody antibody in man: Kinetic and immune response,”Proc. Natl. Acad. Sci. USA, 86:4220-4224, 1989.
Marks et al., “By-passing Immunization Human Antibodies from V-gene Libraries Displayed on Phage,”J. Mol. Biol., 222:581-597, 1991.
Rudikoff et al., “Single amino acid substitution altering antigen-binding specificity,”Proc. Natl. Acad. Sci. USA, 79:1979-1983, 1982.
Sun et al., “Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A,”Proc. Natl. Acad. Sci. 84:214-218, 1987.
Szala et al., “Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2,”Proc. Natl. Acad. Sci. USA, 87:3542-3546, 1990.
William, Fundamental Immunology, 3rdEdition, pp. 292-295, 1993.
Winter et al., “Making antibodies by phage display technology,”Annu Rev Immunol, 12:433-455, 1994.

Affiliated with

Also associated with

Rating

Antibodies that bind human 17-A1/EpCAM tumor antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies that bind human 17-A1/EpCAM tumor antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies that bind human 17-A1/EpCAM tumor antigen will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4104599